Disorders of iron metabolism associated with protease inhibitor therapy [2]

Clinical Infectious Diseases

Volumn 33, Issue 3, 2001, Pages 413-414

  McNabb, JoCarol ^a   Cappa, Joseph A ^b   Ross, Jack W ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; PROTEINASE INHIBITOR; SAQUINAVIR; ZIDOVUDINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; HUMAN; HUMAN TISSUE; IRON METABOLISM; IRON OVERLOAD; LABORATORY TEST; LETTER; LIVER BIOPSY; MALE; PRIORITY JOURNAL;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; IRON OVERLOAD; MALE; MIDDLE AGED;

EID: 0034914082     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/321872     Document Type: Letter

References (6)

1. Measurements of iron status in patients with chronic hepatitis
2. Iron overload in HIV-infected drug users with HAART treatment
3. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: Report of two patients and review of the literature
4. Severe hepatitis in three AIDS patients treated with indinavir
5. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: An immune restoration disease?
6. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV